Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
92,08 USD | +3,17% | +9,41% | +16,66% |
Attività
Numero di dipendenti: 584
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Liver Organ Care System
64,1
%
| 46 | 49,5 % | 152 | 64,1 % | +228,20% |
Heart Organ Care System
30,9
%
| 38 | 41,0 % | 73 | 30,9 % | +90,58% |
Lung Organ Care System
5,0
%
| 9 | 9,5 % | 12 | 5,0 % | +33,60% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
93,5
%
| 84 | 89,9 % | 221 | 93,5 % | +163,39% |
All Other Countries
6,5
%
| 9 | 10,1 % | 15 | 6,5 % | +63,34% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Waleed Hassanein
FOU | Founder | 55 | 01/08/98 |
Stephen Gordon
DFI | Director of Finance/CFO | 56 | 01/03/15 |
Mark Anderson
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/06 |
Laura Damme
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/19 |
Phillip Camp
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/03/19 |
John F. Carey
COO | Chief Operating Officer | 59 | 01/02/06 |
Brian Johnston
IRC | Investor Relations Contact | - | - |
Anil Ranganath
LAW | General Counsel | - | 26/07/23 |
Nick Corcoran
PRN | Corporate Officer/Principal | - | 02/02/23 |
Susan Goodman
HRO | Human Resources Officer | - | 01/01/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Tobin
CHM | Chairman | 79 | 01/01/11 |
Ed Kania
BRD | Director/Board Member | 67 | 01/01/03 |
Merilee Raines
BRD | Director/Board Member | 68 | 01/01/21 |
Thomas Gunderson
BRD | Director/Board Member | 73 | 01/08/16 |
Edward Basile
BRD | Director/Board Member | 76 | 01/02/16 |
Waleed Hassanein
FOU | Founder | 55 | 01/08/98 |
Stephanie Lovell
BRD | Director/Board Member | 64 | 22/03/21 |
David Weill
BRD | Director/Board Member | 60 | 01/01/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 32 851 311 | 31 749 718 ( 96,65 %) | 0 | 96,65 % |
Coordinate società
TransMedics Group, Inc.
200 Minuteman Road Suite 302
01810, Andover
+978 552 0900
http://www.transmedics.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,66% | 3,02 Mrd | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+0,65% | 63,06 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd |
- Borsa valori
- Azioni
- Azione TMDX
- Società TransMedics Group, Inc.